현대바이오
₩6,870
▲ +80.00
(+1.18%)
Volume: 611,506
· 2026-09-23
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
54
- 21d momentum +4.9%
- RSI 52
🎯
Pullback
50
- +4.2% vs 20MA
💎
Value
43
- ROE -4.7%
- Op. margin -1436.9%
- -68% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)52.0
MACD+58
MA trendMixed
ATR7.76%
21d mom.+4.9%
63d mom.-15.6%
vs 20MA+4.2%
RVOL(20)0.40×
52w low · 4,565
52w high · 21,500
-68.0% from 52-week high
20d support 5,780
· resistance 7,730
Computed live from daily OHLCV · as of 2026-09-23
🏦 Fundamentals
ROE-4.7%
Op. margin-1436.9%
Net margin-1636.3%
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2023 | 0.0T | -0.0T | -103.2% |
| 2024 | 0.0T | 0.0T | 5.3% |
| 2025 | 0.0T | -0.0T | -516.3% |
| 2026 | 0.0T | -0.0T | -1436.9% |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum +13.55%, daily vol 4.00%. 현대바이오 sits in a bullish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
+3억
Institution
-1억
Retail
-1억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-23 | +3 | -1 | -1 |
| 09-22 | -6 | -2 | +9 |
| 09-21 | +1 | +2 | -3 |
| 09-18 | +2 | -0 | -2 |
| 09-17 | -6 | +1 | +6 |
Net buy/sell in ₩100M (억). Positive = net buying.